Compression Therapy – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

2012-03-19
Published : Mar-2012

Summary

GlobalData’s new report, “Compression Therapy – Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global compression therapy market. The report provides market landscape, competitive landscape and market trends information on the compression therapy market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

– Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
– Key segments covered include Static Compression Therapy (Ready-to-Wear Legwear, Compression Bandages, Diabetic Shoes and Anti Embolism Stockings) and Dynamic Compression Therapy (Intermittent Pumps and Segmental/Sequential Pumps).
– Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
– Qualitative analysis of key market trends, market drivers, and restraints within compression therapy market.
– The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Compression Therapy Market Forecast

Published: March 2012
No. of Pages: 68
Price- Single User License: US $ 3995                  Corporate User License:US $ 11985

Request Sample

Reasons to buy

– Develop business strategies by understanding the trends and developments that are driving the compression therapy globally.
– Design and develop your product development, marketing and sales strategies.
– Develop market-entry and market expansion strategies.
– Identify key players best positioned to take advantage of the emerging market opportunities.
– Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
– What’s the next big thing in the compression therapy market landscape? – Identify, understand and capitalize.
– Make more informed business decisions from the insightful and in-depth analysis of the global compression therapy market and the factors shaping it.

Few points from Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Disease Overview: Venous Disease 8
3.1 Chronic Venous Disease 8
3.1.1 Heavy Legs 9
3.1.2 Spider Veins 9
3.1.3 Varicose Veins 9
3.1.4 Edemas 9
3.1.5 Stasis Dermatitis 9
3.1.6 Hypodermitis, and Hyperpigmentation 9
3.1.7 Leg Ulcers 10
3.2 Acute Venous Disease 10
3.2.1 Superficial Venous Thrombosis or Phlebitis 10
3.2.2 Deep Vein Thrombosis 10
3.2.3 Pulmonary Embolism 10
3.2.4 Rupture of Varicose Veins 11
3.3 Epidemiology 11
3.4 Economic Burden and Quality of Life 12
4 Device Overview: Compression Therapy 14
4.1 Market Segmentation 14
4.1.1 Static Compression Therapy 15
4.1.2 Dynamic Compression Therapy 16

 

 

Filed in: Medical Device
More Reports
Title Price Buy Now

Ablation Equipments – Medical Devices Pipeline Assessment, 2017

Ablation Equipments - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Ablation Equipments - Medical Devices Pipeline Assessment, 2017" provides an overview of Ablation Equipments currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......
$2500

Sequenom Inc – Medical Equipment – Deals and Alliances Profile

Summary Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby's whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetrici......
$250

Interbody Cages – Medical Devices Pipeline Assessment, 2017

Interbody Cages - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Interbody Cages - Medical Devices Pipeline Assessment, 2017" provides an overview of Interbody Cages currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interbody Cages pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData'......
$2500

Vericel Corp (VCEL) – Medical Equipment – Deals and Alliances Profile

Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell therapy products in the US: Carticel, an autologous chondrocyte implant for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement for the treatment of patients with deep-dermal. The company also develops MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee; and ixmyelocel-T, a patient-specific multicellular therapy for the treating advanced heart failure. It has manufacturing facilities in Cambridge, Massachuset......
$250

West Pharmaceutical Services Inc (WST) – Medical Equipment – Deals and Alliances Profile

Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals for vials, components for intravenous and blood collection systems, prefillable syringe components and systems, advanced injection systems, safety and administration systems, contract design and manufacturing services. The company caters its products to pharmaceutical, biotechnology, generic drug and medical devices companies. It has manufacturing facilities in North America, South America, Europe and Asia-Pacific with affiliated companies in Mexico and Japan. West Pharmaceutical is headquartered......
$250

Zoll Medical Corporation – Medical Equipment – Deals and Alliances Profile

Summary ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for resuscitation and acute critical care victims. Zoll‘s product portfolio includes defibrillators and monitor, automated CPR, hospital software solutions, temperature management systems, ventilators, wearable defibrillator, power infuser, related accessories and others. The company caters its products and solutions to hospitals, public safety, EMS and fire, alternate care, military, and government and homeland security markets. The company operates in North America, Asia-Pacific, Europe, the Middle East and Africa, and Latin America region......
$250

Tesaro Inc (TSRO) – Medical Equipment – Deals and Alliances Profile

Summary Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI, the company's first commercial product is approved for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. The company distributes the product in the US principally through specialty distributors and specialty pharmacy channel. Its development portfolio includes novel cancer and supportive care product candidates in various development stages. Tesaro is headquartered in Waltham, Massachusetts, the US. ......
$250

STMicroelectronics N.V. (STM) – Medical Equipment – Deals and Alliances Profile

Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific integrated circuits, and application specific standard products. The company also has a presence in manufacturing value chain of smartcard products, which include the production and sale of silicon chips and Smartcards. ST uses function-oriented process technologies to produce products. It serves sense and power, and automotive products and embedded processing applications in Singapore, the Netherlands, the US, Japan, France, Italy, and other countries. The company has front-end facilities in Fran......
$250

SeraCare Life Sciences, Inc. – Medical Equipment – Deals and Alliances Profile

Summary SeraCare Life Sciences, Inc. (SeraCare) carries out the discovery, development, manufacture and supply of disease-state specimens and tissues for research and development, processed biological materials, immunoassay reagents and quality control products and technologies. Its major products include next-gen sequencing and digital PCR tools, controls and reference materials, validation and lot qualification materials; plasma and serum diluents/derivatives; cell culture reagents; antibodies and conjugates; and immunoassay reagents and kits. SeraCare's major customers include IVD manufacturers; government and regulatory agencies; and pharmaceutical and biotechnology companies; veterinary companies; and academic and government research organizations. It has facilities in Milford, Massa......
$250

Universal Biosensors Inc (UBI) – Medical Equipment – Deals and Alliances Profile

Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI's major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Aus......
$250